1. Home
  2. ARCH vs KYMR Comparison

ARCH vs KYMR Comparison

Compare ARCH & KYMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARCH
  • KYMR
  • Stock Information
  • Founded
  • ARCH 1969
  • KYMR 2015
  • Country
  • ARCH United States
  • KYMR United States
  • Employees
  • ARCH N/A
  • KYMR N/A
  • Industry
  • ARCH Coal Mining
  • KYMR Medicinal Chemicals and Botanical Products
  • Sector
  • ARCH Energy
  • KYMR Health Care
  • Exchange
  • ARCH Nasdaq
  • KYMR Nasdaq
  • Market Cap
  • ARCH 2.6B
  • KYMR 3.0B
  • IPO Year
  • ARCH 1988
  • KYMR 2020
  • Fundamental
  • Price
  • ARCH $167.01
  • KYMR $44.05
  • Analyst Decision
  • ARCH Buy
  • KYMR Buy
  • Analyst Count
  • ARCH 5
  • KYMR 14
  • Target Price
  • ARCH $173.60
  • KYMR $52.14
  • AVG Volume (30 Days)
  • ARCH 372.9K
  • KYMR 405.5K
  • Earning Date
  • ARCH 11-05-2024
  • KYMR 10-31-2024
  • Dividend Yield
  • ARCH 0.96%
  • KYMR N/A
  • EPS Growth
  • ARCH N/A
  • KYMR N/A
  • EPS
  • ARCH 9.67
  • KYMR N/A
  • Revenue
  • ARCH $2,645,357,000.00
  • KYMR $87,563,000.00
  • Revenue This Year
  • ARCH N/A
  • KYMR N/A
  • Revenue Next Year
  • ARCH N/A
  • KYMR $21.47
  • P/E Ratio
  • ARCH $17.38
  • KYMR N/A
  • Revenue Growth
  • ARCH N/A
  • KYMR 86.92
  • 52 Week Low
  • ARCH $116.44
  • KYMR $18.89
  • 52 Week High
  • ARCH $187.60
  • KYMR $53.27
  • Technical
  • Relative Strength Index (RSI)
  • ARCH 69.15
  • KYMR 42.03
  • Support Level
  • ARCH $163.86
  • KYMR $41.12
  • Resistance Level
  • ARCH $171.87
  • KYMR $53.23
  • Average True Range (ATR)
  • ARCH 5.61
  • KYMR 2.48
  • MACD
  • ARCH 0.33
  • KYMR -0.76
  • Stochastic Oscillator
  • ARCH 85.95
  • KYMR 24.19

About ARCH Arch Resources Inc.

Arch Resources Inc is a producer of metallurgical and coking coal. The company sells its coal to power plants, steel mills, and industrial facilities. Its operating segment includes Metallurgical (MET) and Thermal. It generates maximum revenue from the Metallurgical (MET) segment. Geographically, it derives a majority of its revenue from Asia.

About KYMR Kymera Therapeutics Inc.

Kymera Therapeutics Inc is a biotechnology company pioneering a transformative new approach to treating previously untreatable diseases. The company is advancing the field of targeted protein degradation, accessing the body's innate protein recycling machinery to degrade dysregulated, disease-causing proteins. Kymera's Pegasus targeted protein degradation platform harnesses the body's natural protein recycling machinery to degrade disease-causing proteins, with a focus on un-drugged nodes in validated pathways currently inaccessible with conventional therapeutics. It is accelerating drug discovery with an unmatched ability to target and degrade intractable proteins and advance new treatment options for patients.

Share on Social Networks: